Skip to main content
SpringerLink
Log in

Baclofen for alcohol-use disorders: hospitalisation or death

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Chaignot C, et al. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France. Pharmacoepidemiology and Drug Safety : 25 Sep 2018. Available from: URL: http://doi.org/10.1002/pds.4635

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baclofen for alcohol-use disorders: hospitalisation or death. Reactions Weekly 1723, 7 (2018). https://doi.org/10.1007/s40278-018-52689-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-52689-z

Search

Navigation